Melasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Melasma patients,18-60 years old, no gender restriction; 2. Never received the relevant treatment; 3. After fully understanding the treatment plan and risks, patients voluntarily signed an informed consent form, willing to accept this trial, and cooperate with follow-up.
Exclusion criteria
Exclusion criteria: (1) There are other severe facial spots or pigmentation, which may affect the efficacy evaluation; (2) Similar treatment or clinical trial within the last 3 months; (3) Recent exposure history, or difficulty in achieving sunscreen after treatment; (4) photosensitive or used photosensitive drugs within 2 weeks; (5) Female subjects who are pregnant or lactating. (6) Any active skin disease in the test area; (7) Patients with wound, infection or epidermal ulceration at the test site; (8) Other factors that researchers believe may affect the test results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma area severity index,MASI;PGA; | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfaction assessment; | — |
Countries
China
Contacts
Quzhou Municiple Hospital of Traditonal Chinese Medicine